USARAD, a Nanox Company, Achieves the Joint Commission Re-Certification
Retrieved on:
Wednesday, December 15, 2021
Radiology, Health, Medical Devices, Forward-looking statement, Failure, Hospital, U.S. Securities and Exchange Commission, Joint Commission, Telehealth, Teleradiology, Company, Gold Seal, Algorithm, Health, Growth, Clinic, Accreditation, CAQ, Time, Acquisition, Joint, JCAHO, File, CEO, Research, Patient, Artificial intelligence, Radiology, Ambulatory care, Terminology, Patient safety, MBA, MD, Commission, Maintenance, Compliance, Technology, Medicine, Medical imaging, USARAD Holdings, Inc., Nanox, USARAD HOLDINGS, INC., NANOX
The Joint Commission is the leading accrediting organization in the United States that certifies more than 22,000 health care organizations and programs based on the highest standards of patient safety and quality of care.
Key Points:
- The Joint Commission is the leading accrediting organization in the United States that certifies more than 22,000 health care organizations and programs based on the highest standards of patient safety and quality of care.
- This prestigious designation recognizes an organization's commitment to providing high quality and safe patient care based on ongoing compliance with The Joint Commissions stringent criteria.
- Following an unannounced inspection, USARAD passed in the Ambulatory Care category without any conditions, underscoring the companys dedication to compliance and quality.
- USARAD was initially certified by The Joint Commission in 2009 and is considered among the longest continuously accredited telemedicine companies by The Joint Commission, in fact serving as an industry standard.